Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 1
1977 1
1979 1
1982 2
1983 2
1984 2
1985 4
1986 1
1989 1
1991 1
1993 1
1994 1
1996 3
1997 1
1998 3
1999 3
2000 4
2001 1
2002 3
2003 3
2004 2
2006 1
2007 1
2009 3
2010 1
2011 1
2012 4
2013 1
2014 5
2015 3
2016 3
2017 4
2018 3
2019 3
2020 4
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Hemolytic Anemia due to Disseminated Intravascular Coagulation"
Page 1
Drug-induced immune hemolytic anemia.
Garratty G. Garratty G. Hematology Am Soc Hematol Educ Program. 2009:73-9. doi: 10.1182/asheducation-2009.1.73. Hematology Am Soc Hematol Educ Program. 2009. PMID: 20008184 Review.
Drug-induced immune hemolytic anemia (DIIHA) is rare, and a specialized laboratory is often required to provide the optimal serological tests to confirm the diagnosis. ...In these latter cases, the drug affects the immune system, causing production of red cell (RBC) …
Drug-induced immune hemolytic anemia (DIIHA) is rare, and a specialized laboratory is often required to provide the optimal se …
Typical and Atypical Hemolytic Uremic Syndrome in the Critically Ill.
Manrique-Caballero CL, Peerapornratana S, Formeck C, Del Rio-Pertuz G, Gomez Danies H, Kellum JA. Manrique-Caballero CL, et al. Crit Care Clin. 2020 Apr;36(2):333-356. doi: 10.1016/j.ccc.2019.11.004. Epub 2020 Jan 31. Crit Care Clin. 2020. PMID: 32172817 Review.
Hemolytic uremic syndrome is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. Disseminated intravascular coagulation, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome …
Hemolytic uremic syndrome is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney inj …
Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.
Scully M, Cataland S, Coppo P, de la Rubia J, Friedman KD, Kremer Hovinga J, Lämmle B, Matsumoto M, Pavenski K, Sadler E, Sarode R, Wu H; International Working Group for Thrombotic Thrombocytopenic Purpura. Scully M, et al. J Thromb Haemost. 2017 Feb;15(2):312-322. doi: 10.1111/jth.13571. Epub 2017 Jan 30. J Thromb Haemost. 2017. PMID: 27868334 Free article.
Thrombotic microangiopathy (TMA) is a broad pathophysiologic process that leads to microangiopathic hemolytic anemia and thrombocytopenia, and involves capillary and small-vessel platelet aggregates. The most common cause is disseminated intravascular …
Thrombotic microangiopathy (TMA) is a broad pathophysiologic process that leads to microangiopathic hemolytic anemia and throm …
Thrombotic Microangiopathies (TTP, HUS, HELLP).
Kappler S, Ronan-Bentle S, Graham A. Kappler S, et al. Hematol Oncol Clin North Am. 2017 Dec;31(6):1081-1103. doi: 10.1016/j.hoc.2017.08.010. Hematol Oncol Clin North Am. 2017. PMID: 29078925 Review.
These thrombotic microangiopathies include thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS) and hemolysis, elevated liver enzyme levels, low platelet count (HELLP), which should be distinguished from similar disease processes such as immune thromb …
These thrombotic microangiopathies include thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS) and hemolysis, …
Anesthetic considerations in HELLP syndrome.
del-Rio-Vellosillo M, Garcia-Medina JJ. del-Rio-Vellosillo M, et al. Acta Anaesthesiol Scand. 2016 Feb;60(2):144-57. doi: 10.1111/aas.12639. Epub 2015 Oct 8. Acta Anaesthesiol Scand. 2016. PMID: 26446688 Review.
BACKGROUND: HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) is an obstetric complication with heterogonous presentation and multisystemic involvement. It is characterized by microangiopathic hemolytic anemia, elevated liver enzymes by intravascu …
BACKGROUND: HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) is an obstetric complication with heterogonous presentation an …
Thrombotic microangiopathies (TTP, HUS, HELLP).
Kappler S, Ronan-Bentle S, Graham A. Kappler S, et al. Emerg Med Clin North Am. 2014 Aug;32(3):649-71. doi: 10.1016/j.emc.2014.04.008. Epub 2014 Jun 3. Emerg Med Clin North Am. 2014. PMID: 25060255 Review.
These thrombotic microangiopathies include thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS) and hemolysis, elevated liver enzyme levels, low platelet count (HELLP), which should be distinguished from similar disease processes such as immune thromb …
These thrombotic microangiopathies include thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS) and hemolysis, …
Cancer and thrombosis.
Levi M. Levi M. Clin Adv Hematol Oncol. 2003 Nov;1(11):668-71. Clin Adv Hematol Oncol. 2003. PMID: 16258468 Review.
In most patients with cancer, a procoagulant state can be identified, ranging from subclinical laboratory abnormalities to full-blown disseminated intravascular coagulation. A specific entity is the occurrence of thrombotic microangiopathy that is specificall …
In most patients with cancer, a procoagulant state can be identified, ranging from subclinical laboratory abnormalities to full-blown dis …
Renal venous thrombosis in neonates.
Moudgil A. Moudgil A. Curr Pediatr Rev. 2014;10(2):101-6. doi: 10.2174/157339631002140513101845. Curr Pediatr Rev. 2014. PMID: 25088263 Review.
Laboratory tests may reveal hematuria, proteinuria, polycythemia, hemolytic anemia, thrombocytopenia and possibly acute kidney injury. ...Use of unfractionated heparin (UFH) or low molecular weight heparin (LMWH) should be considered if there is evidence of disse …
Laboratory tests may reveal hematuria, proteinuria, polycythemia, hemolytic anemia, thrombocytopenia and possibly acute kidney …
Thrombotic Thrombocytopenic Purpura, Heparin-Induced Thrombocytopenia, and Disseminated Intravascular Coagulation.
Kalpatthi R, Kiss JE. Kalpatthi R, et al. Crit Care Clin. 2020 Apr;36(2):357-377. doi: 10.1016/j.ccc.2019.12.006. Epub 2020 Feb 6. Crit Care Clin. 2020. PMID: 32172818 Review.
The abnormalities range from isolated thrombocytopenia or prolongation of global coagulation assays to complex disease states, such as thrombotic microangiopathic syndromes, and can be associated with a wide range of conditions, including trauma, surgery, acute disease pro …
The abnormalities range from isolated thrombocytopenia or prolongation of global coagulation assays to complex disease states, such a …
Cancer-related microangiopathic hemolytic anemia: clinical and laboratory features in 168 reported cases.
Lechner K, Obermeier HL. Lechner K, et al. Medicine (Baltimore). 2012 Jul;91(4):195-205. doi: 10.1097/MD.0b013e3182603598. Medicine (Baltimore). 2012. PMID: 22732949 Free article. Review.
Cancer-related microangiopathic hemolytic anemia (CR-MAHA) is a paraneoplastic syndrome characterized by Coombs-negative hemolytic anemia with schistocytes and thrombocytopenia. ...Compared to hereditary or immune TTP or aHUS, disseminated in …
Cancer-related microangiopathic hemolytic anemia (CR-MAHA) is a paraneoplastic syndrome characterized by Coombs-negative he …
79 results